Paola Tellaroli

Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study)

Chiara Fraccaro, Giuseppe Tarantini, Stefano Rosato et al. · The American Journal of Cardiology · 2016 · 39 citations

Cardiovascular Disease, Vascular Surgery, Outcomes Research +9

Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters

Paola Tellaroli, Marco Bazzi, Michele Donato et al. · PLoS ONE · 2016 · 29 citations · Full text

Cluster Computing, Engineering, Genetic Epidemiology +21

Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy

Giuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli et al. · International Journal of Cardiology · 2016 · 25 citations

Thrombosis, Diabetes Management, Dual Antiplatelet Therapy +9

Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve

Luca Nai Fovino, Mostafa Badawy, Chiara Fraccaro et al. · Journal of Cardiovascular Medicine · 2018 · 23 citations · Full text

Absorb bioresorbable vascular scaffold vs. everolimus‐eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD‐ABSORB studies

Giuseppe Tarantini, Giulia Masiero, Alberto Barioli et al. · Catheterization and Cardiovascular Interventions · 2018 · 10 citations